Oramed Pharmaceuticals
ORMP
#9079
Rank
โ‚ฌ0.14 B
Marketcap
3,65ย โ‚ฌ
Share price
3.48%
Change (1 day)
86.67%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): โ‚ฌ66.97 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of โ‚ฌ68.37 Million, an increase over its 2024 earnings that were of -โ‚ฌ13.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ66.97 M-2.04%
2025 โ‚ฌ68.37 M-616.9%
2024 -โ‚ฌ13.23 Million-311.47%
2023 โ‚ฌ6.25 M-119.45%
2022 -โ‚ฌ32.16 Million39.17%
2021 -โ‚ฌ23.11 Million73.93%
2020 -โ‚ฌ13.29 Million18.53%
2019 -โ‚ฌ11.21 Million-16.62%
2018 -โ‚ฌ13.45 Million38.32%
2017 -โ‚ฌ9.72 Million12.51%
2016 -โ‚ฌ8.64 Million25.01%
2015 -โ‚ฌ6.91 Million18.18%
2014 -โ‚ฌ5.85 Million39.72%
2013 -โ‚ฌ4.19 Million46.4%
2012 -โ‚ฌ2.86 Million128.32%
2011 -โ‚ฌ1.26 Million-51.47%
2010 -โ‚ฌ2.58 Million35.21%
2009 -โ‚ฌ1.91 Million
2007 -โ‚ฌ3 Million607.04%
2006 -โ‚ฌ0.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚ฌ21.95 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚ฌ6.72 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.48 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚ฌ22.91 Million-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ30.62 M-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel